ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $41,000 | -32.8% | 870 | +2.1% | 0.00% | – |
| Q1 2022 | $61,000 | +335.7% | 852 | +343.8% | 0.00% | – |
| Q4 2021 | $14,000 | +40.0% | 192 | +5.5% | 0.00% | – |
| Q3 2021 | $10,000 | +25.0% | 182 | -0.5% | 0.00% | – |
| Q2 2021 | $8,000 | -27.3% | 183 | -20.8% | 0.00% | – |
| Q1 2021 | $11,000 | +450.0% | 231 | +477.5% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 40 | +100.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |